China Universal Asset Management Co., Ltd. Reneo Pharmaceuticals, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $893 Million
- Q3 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Reneo Pharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 6,429 shares of RPHM stock, worth $10,800. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,429
Previous 3,927
63.71%
Holding current value
$10,800
Previous $5,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding RPHM
# of Institutions
53Shares Held
31MCall Options Held
50.8KPut Options Held
0-
Nea Management Company, LLC Timonium, MD4.79MShares$8.04 Million0.62% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.46MShares$5.81 Million3.46% of portfolio
-
Highbridge Capital Management LLC New York, NY3.06MShares$5.15 Million1.56% of portfolio
-
Tang Capital Management LLC San Diego, CA2.95MShares$4.95 Million0.43% of portfolio
-
Carlyle Group Inc. Washington, DC2.7MShares$4.53 Million0.69% of portfolio
About Reneo Pharmaceuticals, Inc.
- Ticker RPHM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,479,600
- Market Cap $41.1M
- Description
- Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as w...